Literature DB >> 11781322

Identification of annexin II heterotetramer as a plasmin reductase.

Mijung Kwon1, Jennifer F Caplan, Nolan R Filipenko, Kyu-Sil Choi, Sandra L Fitzpatrick, Libo Zhang, David M Waisman.   

Abstract

Annexin II heterotetramer (AIIt) is a Ca(2+)- and phospholipid-binding protein that consists of two copies of a p36 and p11 subunit. AIIt regulates the production and autoproteolysis of plasmin at the cell surface. In addition to its role as a key cellular protease, plasmin also plays a role in angiogenesis as the precursor for antiangiogenic proteins. Recently we demonstrated that the primary antiangiogenic plasmin fragment, called A(61) (Lys(78)-Lys(468)) was released from cultured cells. In the present study we report for the first time that AIIt possesses an intrinsic plasmin reductase activity. AIIt stimulated the reduction of the plasmin Cys(462)-Cys(541) bond in a time- and concentration-dependent manner, which resulted in the release of A(61) from plasmin. Mutagenesis of p36 C334S and either p11 C61S or p11 C82S inactivated the plasmin reductase activity of the isolated subunits, suggesting that specific cysteinyl residues participated in the plasmin reductase activity of each subunit. Furthermore, we demonstrated that the loss of AIIt from the cell surface of HT1080 cells transduced with a retroviral vector encoding p11 antisense dramatically reduced the cellular production of A(61) from plasminogen. This is the first demonstration that AIIt regulates the cellular production of the antiangiogenic plasminogen fragment, A(61).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781322     DOI: 10.1074/jbc.M111219200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  S100A10 as a novel biomarker in colorectal cancer.

Authors:  Jinfu Shang; Zhanxue Zhang; Weiqing Song; Baojun Zhou; Yuesheng Zhang; Guixin Li; Shaofan Qiu
Journal:  Tumour Biol       Date:  2013-07-05

2.  Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.

Authors:  Diego Butera; Troels Wind; Angelina J Lay; Julia Beck; Francis J Castellino; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface.

Authors:  Mario Gonzalez-Gronow; Rupa Ray; Fang Wang; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

Review 4.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

5.  Dynamic reciprocity: the role of annexin A2 in tissue integrity.

Authors:  Jessica K Hitchcock; Arieh A Katz; Georgia Schäfer
Journal:  J Cell Commun Signal       Date:  2014-05-20       Impact factor: 5.782

6.  tPA receptors and the fibrinolytic response in multiple sclerosis lesions.

Authors:  Djordje Gveric; Blanca M Herrera; M Louise Cuzner
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior.

Authors:  Thomas Foulkes; Mohammed A Nassar; Tim Lane; Elizabeth A Matthews; Mark D Baker; Volker Gerke; Kenji Okuse; Anthony H Dickenson; John N Wood
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

8.  Annexin A2: the importance of being redox sensitive.

Authors:  Patrícia A Madureira; David M Waisman
Journal:  Int J Mol Sci       Date:  2013-02-07       Impact factor: 5.923

9.  Annexin A2 heterotetramer: structure and function.

Authors:  Alamelu Bharadwaj; Moamen Bydoun; Ryan Holloway; David Waisman
Journal:  Int J Mol Sci       Date:  2013-03-19       Impact factor: 5.923

10.  Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.

Authors:  Abhijit G Banerjee; Jie Liu; Yawei Yuan; Velliyur K Gopalakrishnan; Sonny L Johansson; Amit K Dinda; Narmada P Gupta; Lindsey Trevino; Jamboor K Vishwanatha
Journal:  Mol Cancer       Date:  2003-10-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.